USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 190 filers reported holding USANA HEALTH SCIENCES INC in Q2 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,467,390 | -12.1% | 54,540 | -5.7% | 0.00% | -50.0% |
Q1 2024 | $2,806,404 | -13.1% | 57,864 | -4.0% | 0.00% | 0.0% |
Q4 2023 | $3,230,954 | -10.9% | 60,279 | -2.5% | 0.00% | -33.3% |
Q3 2023 | $3,624,794 | -11.6% | 61,846 | -4.9% | 0.00% | 0.0% |
Q2 2023 | $4,100,437 | -4.9% | 65,045 | -5.1% | 0.00% | 0.0% |
Q1 2023 | $4,311,732 | +15.2% | 68,549 | -2.5% | 0.00% | 0.0% |
Q4 2022 | $3,741,768 | -6.2% | 70,334 | -1.2% | 0.00% | 0.0% |
Q3 2022 | $3,989,000 | -29.0% | 71,153 | -8.3% | 0.00% | -25.0% |
Q2 2022 | $5,617,000 | -13.9% | 77,627 | -5.5% | 0.00% | 0.0% |
Q1 2022 | $6,527,000 | -26.1% | 82,156 | -5.9% | 0.00% | -20.0% |
Q4 2021 | $8,837,000 | +0.7% | 87,320 | -8.2% | 0.01% | -16.7% |
Q3 2021 | $8,773,000 | -7.5% | 95,150 | +2.8% | 0.01% | 0.0% |
Q2 2021 | $9,480,000 | -0.9% | 92,553 | -5.5% | 0.01% | -14.3% |
Q1 2021 | $9,564,000 | +26.3% | 97,991 | -0.2% | 0.01% | +16.7% |
Q4 2020 | $7,572,000 | +5.9% | 98,205 | +1.2% | 0.01% | 0.0% |
Q3 2020 | $7,147,000 | +0.3% | 97,038 | -0.0% | 0.01% | 0.0% |
Q2 2020 | $7,128,000 | +18.3% | 97,069 | -6.9% | 0.01% | -14.3% |
Q1 2020 | $6,024,000 | -29.0% | 104,294 | -3.5% | 0.01% | 0.0% |
Q4 2019 | $8,489,000 | +13.6% | 108,065 | -1.1% | 0.01% | 0.0% |
Q3 2019 | $7,471,000 | -17.4% | 109,244 | -4.0% | 0.01% | -12.5% |
Q2 2019 | $9,041,000 | +1480.6% | 113,825 | +1569.5% | 0.01% | +700.0% |
Q1 2019 | $572,000 | -45.5% | 6,818 | -23.6% | 0.00% | 0.0% |
Q4 2018 | $1,050,000 | -9.5% | 8,922 | -7.2% | 0.00% | 0.0% |
Q3 2018 | $1,160,000 | +13.3% | 9,618 | +8.3% | 0.00% | 0.0% |
Q2 2018 | $1,024,000 | +146.2% | 8,881 | +22.9% | 0.00% | 0.0% |
Q1 2017 | $416,000 | -5.9% | 7,224 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $442,000 | +104.6% | 7,224 | +152.3% | 0.00% | – |
Q1 2014 | $216,000 | -1.4% | 2,863 | -1.0% | 0.00% | – |
Q4 2013 | $219,000 | -12.7% | 2,891 | 0.0% | 0.00% | -100.0% |
Q3 2013 | $251,000 | +4.1% | 2,891 | -13.2% | 0.00% | 0.0% |
Q2 2013 | $241,000 | – | 3,332 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |